TrialCNS drugs2014

Health-related quality of life and functional outcomes from a randomized-withdrawal study of long-term lisdexamfetamine dimesylate treatment in children and adolescents with attention-deficit/hyperactivity disorder.

Tobias Banaschewski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.